In 2021, the Danish Medicines Council processed 50 new drug applications. Unfortunately, the established allotted case processing time of 84 days was exceeded with every application. This is the fifth year in a row that case processing got behind schedule, according to the council’s latest year-in-review.
This is not sustainable for the patients, the healthcare system or the companies. That’s why it’s good that the Danish Medicines Council has stated it welcomes proposals for how to improve. We would like to acknowledge this.